Region: United States of America

IBM defeats antitrust claim by LzLabs in patent dispute

Big Blue’s infringement and trade secret litigation now proceeds to discovery in Texas case against the smaller mainframe software company

29 March 2023

Janssen’s latest move against Amgen highlights shifting pharma patent strategies

J&J subsidiary makes innovative use of IP acquired in $6.5 billion Momenta acquisition

28 March 2023

Adeia licenses Kioxia and Western Digital to semiconductor portfolio

The new long-term agreements with both 3D NAND memory manufacturers includes Adeia's hybrid bonding rights

28 March 2023

Why evidence remains king when it comes to pricing SEPs

Featured in SEP/FRAND Hub

A thorough analysis of US courts’ applications of both the top-down and bottom-up frameworks highlights the strengths and weaknesses of the two approaches and what they mean for both licensors and licensees.

28 March 2023

Blackberry patent buyer’s US litigation track record

Key Patent Innovations has a scant history of suing in the States, indicating its licensing approach may centre on private negotiations in contrast to the failed purchaser

27 March 2023

Via Licensing taps Xiaomi’s former IP strategy head as advisor

Paul Lin, now managing director of Eagle Forest, aims to provide the licensee’s perspective to arm Via as it navigates a shifting patent pool landscape

23 March 2023

InterDigital’s UK setback highlights patent litigation risks

In retrospect, the US R&D and licensing business would surely have preferred to take a hit in order to settle its dispute with Lenovo out of sight and in secret

23 March 2023

Holistic IP strategy layering multiple forms of protection covers innovation at Waymo

In an exclusive interview, IP head Van Nguy reveals her rubric for building a foundational portfolio on emerging tech including a mix of patents, trade secrets and trade dress

22 March 2023

Examining the practice of Cedar Lane Technologies – America’s top-filing NPE

We talked with Greg Benoit, president of the Canadian company that filed the most cases in 2022, strongly favours the Western District of Texas, and has obtained a 96% settlement rate among its terminated cases

20 March 2023

We need a better debate about US pharma patents

Opinion: Popular attacks on America’s life sciences patent system are highly misleading

18 March 2023

Unlock unlimited access to all IAM content